News | Womens Cardiovascular Health | February 09, 2022

SCAI Releases Expert Consensus on Gender-specific Considerations in Myocardial Revascularization

Figure 1Recommended Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention. ∗While not marketed in the United States, DCBs are available for clinical use in Canada, with 1-3 months of DAPT recommended. DAPT = dual antiplatelet therapy; LD, limited data. Reprinted from Capodanno D, Alfonso F, Levine GN, Valgimigli M, Angiolillo DJ. ACC/AHA versus ESC guidelines on dual antiplatelet therapy: JACC guideline comparison. J Am Coll Cardiol. 2018;72(23 Pt A):2915-2931, with permission from

February 9, 2022 — A newly released expert consensus statement on sex-specific considerations in myocardial revascularization aims to summarize available literature on myocardial revascularization in women and identify important gaps in evidence. The document was published today in the Journal of the Society for Cardiovascular Angiography & Interventions (JSCAI), the official journal of SCAI.

Cardiovascular disease is the leading cause of death and disability in women globally, claiming the lives of nearly 8.5 million women each year. Utilization of cardiovascular procedures is far lower in women than men, and women continue to be underrepresented in cardiovascular clinical trials, severely limiting the opportunity to better understand sex differences in cardiovascular drug or device outcomes. Current practice guidelines do not address gender-based differences and fail to highlight when insufficient evidence exists regarding cardiovascular outcomes in women, resulting in overall poorer outcomes.

“This consensus is an international collaborative effort that highlights the knowns, the gaps and ambiguities in evidence related to sex-specific revascularization,” said Alexandra Lansky, MD, FSCAI, Chair of the document, Professor of Medicine in the section of Cardiology at the Yale School of Medicine and a practicing cardiologist at Yale-New Haven Hospital. Lansky is also Editor-in-Chief of JSCAI.  “As a companion to the recent percutaneous coronary intervention (PCI) guidelines, it will inform clinicians on best practices most relevant to our female patients and draws attention to areas in need of additional evidence,” Lansky continued. 

The paper explores gaps in evidence in several areas including the epidemiology of ischemic heart disease, diagnostic tools to guide coronary revascularization, revascularization for chronic coronary syndromes, revascularization for non-ST-elevation myocardial infarction (MI) and ST-elevation MI, and revascularization consideration for specific patient populations, vascular access in women, and more.

“Physicians can use this consensus document to inform their discussions with female patients on the risks and benefits of coronary revascularization,” said J. Dawn Abbott, MD, FSCAI, Co-Chair of the document and Professor of Medicine and Director of the Interventional Cardiology Fellowship Training Program at Brown Medical School. “An understanding of the limitations of the data is important in this regard,” Abbott concluded. 

Authors of the paper state that while the evidence supporting clinical decisions in women is lacking, these findings are important to guide prospective investigation and establish research priorities. 

For more information: www.scai.org


Related Content

News | SCAI

May 10, 2022 — After two years of virtual meetings, the Society for Cardiovascular Angiography & Interventions (SCAI) ...

Home May 10, 2022
Home
Feature | SCAI

May 21, 2020 — Here is the list of late-breaking study presentations and links to articles about each of them from the ...

Home May 21, 2020
Home
News | SCAI

May 17, 2020 – A new study shows that when compared with patients without intermediate left main coronary artery disease ...

Home May 17, 2020
Home
News | SCAI

May 17, 2020 — Cindy Grines, M.D., MSCAI, a world-renowned physician credited for pioneering percutaneous coronary ...

Home May 17, 2020
Home
Feature | SCAI

May 8, 2019 — The Society for Cardiovascular Angiography and Interventions (SCAI) 2019 Scientific Sessions will take ...

Home May 08, 2019
Home
Feature | SCAI | Subhash Banerjee, M.D., FSCAI, Abu-Fadel Mazen, M.D., FSCAI and Rajesh Swaminathan, M.D., FSCAI

The Society for Cardiovascular Angiography and Interventions (SCAI) 2019 Scientific Sessions in Las Vegas, May 19-22 ...

Home February 25, 2019
Home
Feature | SCAI

Here is an aggregation of all the news and late-breaking studies presented at the 2018 Society for Cardiovascular ...

Home May 14, 2018
Home
Feature | SCAI

May 30, 2017 — The Society for Cardiovascular Angiography and Interventions (SCAI) 2017 Scientific Sessions took place ...

Home May 01, 2017
Home
Subscribe Now